Press Releases WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 17/11/2025			5-day change	1st Jan Change
93.76 ^CNY	-1.33%		-1.14%	+70.35%

10/11	BlackRock's long position in H-shares of Wuxi Apptec increases to 5.48% on Nov 5 - HKEX	RE
29/10	Wuxi Apptec's shareholders to cut 2% A-shares	RE

Press Releases

WuXi AppTec : Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance	26/10	PU
WuXi AppTec : Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance	26/10	PU
WuXi AppTec : Unveils Modernized Logo, Reflecting Continued Evolution as a Global Healthcare Partner	26/10	PU
WuXi AppTec : 2025 Third Quarterly Results Presentation	26/10	PU
WuXi AppTec : Signs Definitive Agreement to Sell China-based Clinical Research Services Business to Hillhouse	26/10	PU
BIOSECURE Included In Draft National Defense Authorization Act Of 2026	14/10	AQ
WuXi AppTec : 2025 WuXi AppTec Investor Day - Financial Performance	26/09	PU
WuXi AppTec : 2025 WuXi AppTec Investor Day - Research Enabling Platforms	26/09	PU
WuXi AppTec : Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled	28/08	PU
WuXi AppTec : Achieves Strong Growth in Revenue and Profit for Q2 and H1 2025, H1 Revenue from Continuing Operations Up 24.2% YoY, and Adjusted Non-IFRS Net Profit Up 44.4% YoY; Backlog for Continuing Operations Up 37.2% YoY	28/07	PU
WuXi AppTec : 2025 Interim Results Presentation	28/07	PU
WuXi AppTec Provides Updates on Q2 Share Repurchase, Acquisition Activities	08/07	AQ
WuXi AppTec Receives MSCI ESG AAA Leader Rating	08/07	AQ
WuXi AppTec : 2024 Annual Results Presentation	17/03	PU
WuXi AppTec : Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs	17/03	PU
WuXi AppTec : Completes Sale of U.S. Medical Device Testing Operations	03/03	PU
WuXi AppTec : Signs Definitive Agreement to Sell U.S. Medical Device Testing Operations to NAMSA	17/01	PU
WuXi AppTec : 43th J.P. Morgan Healthcare Conference Main Track Presentation Audio Webcast	13/01	PU
WuXi AppTec Listed in TIME Magazine's World's Best Companies in Sustainable Growth 2025	06/01	AQ
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment	12/11	AQ
WuXi AppTec : 2024 Third Quarterly Results Presentation	28/24/28	PU
BIOSECURE Act: US To Target Chinese Biotechnology Companies	27/24/27	AQ
WuXi AppTec : 2024 WuXi AppTec Investor Day - Financial Performance	26/24/26	PU
WuXi AppTec : 2024 WuXi AppTec Investor Day - WuXi Chemistry (CRDMO)	26/24/26	PU
WuXi AppTec : 2024 WuXi AppTec Investor Day - Research Enabling Platforms	26/24/26	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

Press Releases

Filters